SLO-1-channels of parasitic nematodes reconstitute locomotor behaviour and emodepside sensitivity in Caenorhabditis elegans slo-1 loss of function mutants
- PMID: 21490955
- PMCID: PMC3072372
- DOI: 10.1371/journal.ppat.1001330
SLO-1-channels of parasitic nematodes reconstitute locomotor behaviour and emodepside sensitivity in Caenorhabditis elegans slo-1 loss of function mutants
Abstract
The calcium-gated potassium channel SLO-1 in Caenorhabditis elegans was recently identified as key component for action of emodepside, a new anthelmintic drug with broad spectrum activity. In this study we identified orthologues of slo-1 in Ancylostoma caninum, Cooperia oncophora, and Haemonchus contortus, all important parasitic nematodes in veterinary medicine. Furthermore, functional analyses of these slo-1 orthologues were performed using heterologous expression in C. elegans. We expressed A. caninum and C. oncophora slo-1 in the emodepside-resistant genetic background of the slo-1 loss-of-function mutant NM1968 slo-1(js379). Transformants expressing A. caninum slo-1 from C. elegans slo-1 promoter were highly susceptible (compared to the fully emodepside-resistant slo-1(js379)) and showed no significant difference in their emodepside susceptibility compared to wild-type C. elegans (p = 0.831). Therefore, the SLO-1 channels of A. caninum and C. elegans appear to be completely functionally interchangeable in terms of emodepside sensitivity. Furthermore, we tested the ability of the 5' flanking regions of A. caninum and C. oncophora slo-1 to drive expression of SLO-1 in C. elegans and confirmed functionality of the putative promoters in this heterologous system. For all transgenic lines tested, expression of either native C. elegans slo-1 or the parasite-derived orthologue rescued emodepside sensitivity in slo-1(js379) and the locomotor phenotype of increased reversal frequency confirming the reconstitution of SLO-1 function in the locomotor circuits. A potent mammalian SLO-1 channel inhibitor, penitrem A, showed emodepside antagonising effects in A. caninum and C. elegans. The study combined the investigation of new anthelmintic targets from parasitic nematodes and experimental use of the respective target genes in C. elegans, therefore closing the gap between research approaches using model nematodes and those using target organisms. Considering the still scarcely advanced techniques for genetic engineering of parasitic nematodes, the presented method provides an excellent opportunity for examining the pharmacofunction of anthelmintic targets derived from parasitic nematodes.
Conflict of interest statement
Achim Harder is employed by BayerHealthCare AG, which is developing veterinary pharmaceuticals including antiparasiticdal drugs like emodepside. This study was performed as a collaborative research project between Bayer HealthCare AG and the Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin as well as previously the Institute for Parasitology at the University of Veterinary Medicine, Hannover. Accordingly, both academic institutions received project specific reseach grants from Bayer HealthCare AG.
Figures





Similar articles
-
Worms take to the slo lane: a perspective on the mode of action of emodepside.Invert Neurosci. 2012 Jun;12(1):29-36. doi: 10.1007/s10158-012-0133-x. Epub 2012 Apr 27. Invert Neurosci. 2012. PMID: 22539031 Free PMC article. Review.
-
Characterization of the Ca2+-gated and voltage-dependent K+-channel Slo-1 of nematodes and its interaction with emodepside.PLoS Negl Trop Dis. 2014 Dec 18;8(12):e3401. doi: 10.1371/journal.pntd.0003401. eCollection 2014 Dec. PLoS Negl Trop Dis. 2014. PMID: 25521608 Free PMC article.
-
The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans.Int J Parasitol. 2007 Dec;37(14):1577-88. doi: 10.1016/j.ijpara.2007.05.006. Epub 2007 May 21. Int J Parasitol. 2007. PMID: 17583712
-
Natural variation in Caenorhabditis elegans responses to the anthelmintic emodepside.Int J Parasitol Drugs Drug Resist. 2021 Aug;16:1-8. doi: 10.1016/j.ijpddr.2021.04.001. Epub 2021 Apr 17. Int J Parasitol Drugs Drug Resist. 2021. PMID: 33878514 Free PMC article.
-
SLO, SLO, quick, quick, slow: calcium-activated potassium channels as regulators of Caenorhabditis elegans behaviour and targets for anthelmintics.Invert Neurosci. 2007 Dec;7(4):199-208. doi: 10.1007/s10158-007-0057-z. Epub 2007 Oct 26. Invert Neurosci. 2007. PMID: 17962986 Review.
Cited by
-
Transgenically expressed Parascaris P-glycoprotein-11 can modulate ivermectin susceptibility in Caenorhabditis elegans.Int J Parasitol Drugs Drug Resist. 2015 Apr 8;5(2):44-7. doi: 10.1016/j.ijpddr.2015.03.003. eCollection 2015 Aug. Int J Parasitol Drugs Drug Resist. 2015. PMID: 25905032 Free PMC article.
-
Indole diterpene alkaloids as novel inhibitors of the Wnt/β-catenin pathway in breast cancer cells.Eur J Med Chem. 2013;70:594-606. doi: 10.1016/j.ejmech.2013.09.045. Epub 2013 Oct 8. Eur J Med Chem. 2013. PMID: 24211635 Free PMC article.
-
Caenorhabditis elegans in anthelmintic research - Old model, new perspectives.Int J Parasitol Drugs Drug Resist. 2020 Dec;14:237-248. doi: 10.1016/j.ijpddr.2020.09.005. Epub 2020 Oct 2. Int J Parasitol Drugs Drug Resist. 2020. PMID: 33249235 Free PMC article. Review.
-
Structural and functional characterization of a novel gene, Hc-daf-22, from the strongylid nematode Haemonchus contortus.Parasit Vectors. 2016 Jul 29;9(1):422. doi: 10.1186/s13071-016-1704-1. Parasit Vectors. 2016. PMID: 27472920 Free PMC article.
-
Efficacy of cyclooctadepsipeptides and aminophenylamidines against larval, immature and mature adult stages of a parasitologically characterized trichurosis model in mice.PLoS Negl Trop Dis. 2014 Feb 20;8(2):e2698. doi: 10.1371/journal.pntd.0002698. eCollection 2014 Feb. PLoS Negl Trop Dis. 2014. PMID: 24587460 Free PMC article.
References
-
- Jasmer DP, Goverse A, Smant G. Parasitic nematode interactions with mammals and plants. Annu Rev Phytopathol. 2003;41:245–270. - PubMed
-
- Wolstenholme AJ, Fairweather I, Prichard R, Samson-Himmelstjerna G, Sangster NC. Drug resistance in veterinary helminths. Trends Parasitol. 2004;20:469–476. - PubMed
-
- De Clercq D, Sacko M, Behnke J, Gilbert F, Dorny P, et al. Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. Am J Trop Med Hyg. 1997;57:25–30. - PubMed
-
- Reynoldson JA, Behnke JM, Pallant LJ, Macnish MG, Gilbert F, et al. Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. Acta Trop. 1997;68:301–12. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous